Mianyang Di'ao Pharmaceutical

Mianyang Di'ao Pharmaceutical is a key subsidiary of the Di'ao Group, one of China's leading pharmaceutical conglomerates. Based in Mianyang, Sichuan, the company focuses on the research, development, and large-scale production of both traditional Chinese medicines (TCM) and modern chemical drugs. Its flagship product line includes cardiovascular treatments derived from natural saponins, most notably the Di'ao Xinxuekang series, which is widely used in China for treating coronary heart disease and angina. The company operates advanced manufacturing facilities that are GMP-certified, ensuring high-quality standards for the domestic and international markets. Mianyang Di'ao Pharmaceutical plays a critical role in the parent group's vertical integration strategy, combining natural resource extraction with pharmaceutical formulation.